Stage III Lung Cancer
Oncology·MeSH: Lung Neoplasms
2 drugs in development·2 companies·1 clinical trial
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| Pemetrexed | ENANTA PHARMACEUTICALS INC (ENTA) |
Phase 1(1)
| Drug | Company |
|---|---|
| Pemetrexed | ADMA BIOLOGICS, INC. (ADMA) |
Frequently asked questions
How many drugs are in development for Stage III Lung Cancer?
BioSniper tracks 2 drugs in development for Stage III Lung Cancer across 2 companies.
How many clinical trials target Stage III Lung Cancer?
There are 1 clinical trial targeting Stage III Lung Cancer tracked by BioSniper.
Deep-dive into Stage III Lung Cancer
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis